Logo image of MDVL

MEDAVAIL HOLDINGS INC (MDVL) Stock Fundamental Analysis

NASDAQ:MDVL - Nasdaq - US58406B2025 - Common Stock - Currency: USD

1.8  -1.23 (-40.59%)

After market: 1.78 -0.02 (-1.11%)

Fundamental Rating

3

Taking everything into account, MDVL scores 3 out of 10 in our fundamental rating. MDVL was compared to 40 industry peers in the Consumer Staples Distribution & Retail industry. The financial health of MDVL is average, but there are quite some concerns on its profitability. While showing a medium growth rate, MDVL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

MDVL had negative earnings in the past year.
In the past year MDVL has reported a negative cash flow from operations.
MDVL had negative earnings in each of the past 5 years.
MDVL had a negative operating cash flow in each of the past 5 years.
MDVL Yearly Net Income VS EBIT VS OCF VS FCFMDVL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -10M -20M -30M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -153.79%, MDVL is doing worse than 92.86% of the companies in the same industry.
With a Return On Equity value of -199.57%, MDVL is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -153.79%
ROE -199.57%
ROIC N/A
ROA(3y)-99.1%
ROA(5y)-101.93%
ROE(3y)-167.47%
ROE(5y)-195.52%
ROIC(3y)N/A
ROIC(5y)N/A
MDVL Yearly ROA, ROE, ROICMDVL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 -100 -200 -300

1.3 Margins

Looking at the Gross Margin, with a value of 6.71%, MDVL is doing worse than 88.10% of the companies in the same industry.
MDVL's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for MDVL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-54.1%
GM growth 5Y-32.06%
MDVL Yearly Profit, Operating, Gross MarginsMDVL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -1K -2K -3K

5

2. Health

2.1 Basic Checks

MDVL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MDVL has more shares outstanding
MDVL has a better debt/assets ratio than last year.
MDVL Yearly Shares OutstandingMDVL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 500K 1M 1.5M
MDVL Yearly Total Debt VS Total AssetsMDVL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M

2.2 Solvency

MDVL has an Altman-Z score of -13.83. This is a bad value and indicates that MDVL is not financially healthy and even has some risk of bankruptcy.
MDVL has a worse Altman-Z score (-13.83) than 95.24% of its industry peers.
MDVL has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
MDVL has a better Debt to Equity ratio (0.07) than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z -13.83
ROIC/WACCN/A
WACC5.37%
MDVL Yearly LT Debt VS Equity VS FCFMDVL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M -40M 60M

2.3 Liquidity

MDVL has a Current Ratio of 6.50. This indicates that MDVL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 6.50, MDVL belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
A Quick Ratio of 4.08 indicates that MDVL has no problem at all paying its short term obligations.
MDVL's Quick ratio of 4.08 is amongst the best of the industry. MDVL outperforms 92.86% of its industry peers.
Industry RankSector Rank
Current Ratio 6.5
Quick Ratio 4.08
MDVL Yearly Current Assets VS Current LiabilitesMDVL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M

6

3. Growth

3.1 Past

MDVL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -115.54%.
MDVL shows a strong growth in Revenue. In the last year, the Revenue has grown by 71.76%.
MDVL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 141.02% yearly.
EPS 1Y (TTM)-115.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.92%
Revenue 1Y (TTM)71.76%
Revenue growth 3Y247.2%
Revenue growth 5Y141.02%
Sales Q2Q%-24.07%

3.2 Future

The Earnings Per Share is expected to grow by 18.86% on average over the next years. This is quite good.
Based on estimates for the next years, MDVL will show a very strong growth in Revenue. The Revenue will grow by 51.08% on average per year.
EPS Next Y99.29%
EPS Next 2Y41.31%
EPS Next 3Y25.95%
EPS Next 5Y18.86%
Revenue Next Year-92.96%
Revenue Next 2Y-59.93%
Revenue Next 3Y-23.82%
Revenue Next 5Y51.08%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MDVL Yearly Revenue VS EstimatesMDVL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
MDVL Yearly EPS VS EstimatesMDVL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -100 -200 -300 -400 -500

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MDVL. In the last year negative earnings were reported.
Also next year MDVL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDVL Price Earnings VS Forward Price EarningsMDVL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MDVL Per share dataMDVL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 -20 -30 -40

4.3 Compensation for Growth

A more expensive valuation may be justified as MDVL's earnings are expected to grow with 25.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.31%
EPS Next 3Y25.95%

0

5. Dividend

5.1 Amount

MDVL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MEDAVAIL HOLDINGS INC

NASDAQ:MDVL (2/12/2024, 8:00:01 PM)

After market: 1.78 -0.02 (-1.11%)

1.8

-1.23 (-40.59%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)01-23 2024-01-23/amc
Earnings (Next)04-11 2024-04-11/amc
Inst Owners2.97%
Inst Owner Change0%
Ins Owners1666.28%
Ins Owner Change0%
Market Cap2.90M
Analysts82.86
Price Target4.08 (126.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)13%
Min Revenue beat(2)-47.18%
Max Revenue beat(2)73.17%
Revenue beat(4)2
Avg Revenue beat(4)6.66%
Min Revenue beat(4)-47.18%
Max Revenue beat(4)73.17%
Revenue beat(8)4
Avg Revenue beat(8)-19.88%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B 0.13
P/tB 0.13
EV/EBITDA N/A
EPS(TTM)-43
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-19.96
FCFYN/A
OCF(TTM)-19.59
OCFYN/A
SpS14.81
BVpS14.32
TBVpS13.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -153.79%
ROE -199.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.71%
FCFM N/A
ROA(3y)-99.1%
ROA(5y)-101.93%
ROE(3y)-167.47%
ROE(5y)-195.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-54.1%
GM growth 5Y-32.06%
F-Score5
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 14.05%
Cap/Sales 2.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.5
Quick Ratio 4.08
Altman-Z -13.83
F-Score5
WACC5.37%
ROIC/WACCN/A
Cap/Depr(3y)31.8%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.78%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-115.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.92%
EPS Next Y99.29%
EPS Next 2Y41.31%
EPS Next 3Y25.95%
EPS Next 5Y18.86%
Revenue 1Y (TTM)71.76%
Revenue growth 3Y247.2%
Revenue growth 5Y141.02%
Sales Q2Q%-24.07%
Revenue Next Year-92.96%
Revenue Next 2Y-59.93%
Revenue Next 3Y-23.82%
Revenue Next 5Y51.08%
EBIT growth 1Y6.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year79.71%
EBIT Next 3Y23.52%
EBIT Next 5Y17%
FCF growth 1Y27.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.46%
OCF growth 3YN/A
OCF growth 5YN/A